Value of circular RNA in the diagnosis and treatment of nonalcoholic fatty liver disease
10.3969/j.issn.1001-5256.2021.11.043
- VernacularTitle:circRNA在非酒精性脂肪性肝病诊治中的应用价值
- Author:
Shengnan DU
1
;
Jingjing GAO
1
;
Tao WANG
1
;
Yuanye JIANG
1
;
Qin CAO
1
Author Information
1. Department of Gastroenterology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China
- Publication Type:Reviews
- Keywords:
Non-alcoholic Fatty Liver Disease;
Circular RNA;
Diagnosis;
Therapeutics
- From:
Journal of Clinical Hepatology
2021;37(11):2684-2688
- CountryChina
- Language:Chinese
-
Abstract:
The prevalence rate of nonalcoholic fatty liver disease (NAFLD) is increasing year by year and it has become one of the most common chronic liver diseases in the world. Studies have shown that circular RNA (circRNA) is closely associated with NAFLD and is considered a potential diagnostic biomarker and therapeutic target for NAFLD. This article summarizes the regulatory role of circRNA in the pathogenesis of NAFLD and its value in diagnosis and treatment and points out that circRNA plays an important role in the development and progression of NAFLD and may have important clinical significance in the diagnosis and treatment of NAFLD.
